Indian Council of Medical Research
Indian Council of Medical Research ▸ Facts ▸ Comments ▸ News ▸ Videos
‘No difference in Covid death percentage between first & second wave’: ICMR D-G
Credit: HT Digital Content Duration: 01:57Published
No difference in death percentage between 1st and 2nd COVID wave: ICMR DG
Credit: ANI Duration: 01:03Published
COVID-19: India reports spike of over 2.6 lakh cases
Credit: ANI Duration: 01:43Published
COVID-19: India continues to report spike of over 2 lakh cases
Credit: ANI Duration: 01:43Published
COVID-19: India records highest ever spike of 2.17 lakh cases
Credit: ANI Duration: 01:40Published
High-level committee constituted for Eco-Health Initiatives in India: Harsh Vardhan
Credit: ANI Duration: 02:03Published
People's health closely connected with that of animals': Harsh Vardhan
Credit: ANI Duration: 01:40Published
COVID-19: India reports 1,52,879 new cases, highest ever single-day spike
Credit: ANI Duration: 01:30Published
With 780 deaths in 24 hours, India sees most COVID deaths in 2021
Credit: ANI Duration: 01:12Published
COVID update: India records highest ever spike with 1.26 lakh new cases
Credit: ANI Duration: 01:39Published
COVID update: India records highest ever spike of 1.15 lakh cases
Credit: ANI Duration: 01:11Published
COVID update: 96,982 new cases reported in India
Credit: ANI Duration: 02:30Published
IPL 2021: Tournament to be played with restrictions, without audience, informs Nawab Malik
Credit: ANI Duration: 01:45Published
With over 89k COVID cases, India reports highest spike of 2021
Credit: ANI Duration: 01:27Published
India reports 81,466 new COVID infections, highest in 2021
Credit: ANI Duration: 01:42Published
Covid: Centre explains 5 steps discussed with States to curb virus spread
Credit: HT Digital Content Duration: 09:52Published
You Might Like
Adhering to guidelines of ICMR, not under-reporting Covid deaths: Gujarat CM
Covid-19 vaccines are disease-modifying, reduce chances of severe infection, mortality: ICMR chiefCovid-19 vaccines reduce the chances of developing severe infection and mortality, ICMR chief Balram Bhargava said on Tuesday.
No India variant of virus seen so far, says ICMR
Covishield, Covaxin effective against UK, Brazillian variants; work against South African strain on: GovtBoth Covishield and Covaxin vaccines are effective against the UK and the Brazillian variants of coronavirus, while the work against the South African strain was on at several laboratories, the Centre..
India records 53,476 new Covid-19 cases, 251 deathsAccording to the Indian Council of Medical Research (ICMR), as many as 10,65,021 samples were tested on March 24. "The total number of samples tested up to March 24 is 23,75,03,882 including 10,65,021..
Covaxin shows 81% efficacy, say ICMR and Bharat BiotechThis interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccine’s co-developer, the Indian Council for Medical Research (ICMR), said in a statement. The..
PM Modi takes the shot, gives vaccine process a booster doseThe PM, who is 70, was administered Covaxin, the indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). This decision too seemed deliberate..
'Pata hi nahi chala': PM Modi on taking the first shot of COVID-19 vaccinePM Modi was administered Covaxin, developed by biotechnology firm Bharat Biotech and the Indian Council of Medical Research.
No evidence so far to link surge in Covid cases to new variants: ICMREven as some states witness a sudden spike in Covid cases, the scientific evidence so far does not suggest any link between new variants of coronavirus detected in the country and the rise in cases,..
India's COVID-19 vaccines will be effective against new variants: ICMRStressing on the efficacy of indigenous COVID-19 vaccines, the Indian Council of Medical Research (ICMR) on Thursday said interim results of the ongoing clinical trials indicated that they would be..
Covid-19: Can our vaccine fight new strains? India to testThe efficacy of the two Indian vaccines currently in use — Covishield and Covaxin — is likely to be tested against the Brazil and South Africa variants soon, scientists have said. The Indian..
South Africa, Brazil mutated Covid strains have reached IndiaThe South African and Brazilian mutant strains of coronavirus have entered the country, apart from the UK variant reported in 187 people so far. Four persons were detected with the South Africa variant..
Punjab records highest prevalence of high blood pressure: ICMR study
1 in every 5 adults had Covid by mid-Dec, says ICMR surveyMore than one-fifth of the country's adult population had at some point been infected by Covid-19 by mid-December, the third serological survey, conducted between December 17 and January 8 by ICMR..
Those on blood thinners can receive vaccine, says ICMRFact-sheets of both Covaxin and Covishield will be revised soon so that people on blood thinners like aspirin and clopidogrel can receive the vaccines, while those on anticoagulants may also take the..
Covaxin effective on UK virus strain of Covid-19: ICMRAn Indian Council of Medical Research (ICMR) study on Covaxin shows a comparable neutralization activity of the vaccinated individuals against UK-variant strain.
Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet studyIndia's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the..
Vaccine drive accelerates, doses reach far corners of IndiaWhile SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and..
No irregularity in approval to Covaxin: ICMRIn an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2..
All-India vaccine rollout set for next week: GovtThe government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
During pandemic, vaccine's restricted use considered based on safety, immunogenicity data: ICMR chief
Emergency use of vaccine is based on safety, immunogenicity data, says ICMR chiefThe Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and..
From abroad, Rahul directing Cong rumour-mongering: BJPIntensifying attack on Congress for questioning the DCGI’s approval to Covid vaccines, BJP on Monday said Rahul Gandhi, while on a vacation abroad, choreographed rumour-mongering by enlisting his..
ICMR says clinical trial shows COVAXIN is 'safe'Notably, COVAXIN is an indigenously developed coronavirus vaccine manufactured by Bharat Biotech in collaboration with the ICMR.
In a 1st, NIV-Pune isolates, cultures Covid's UK variantPune's National Institute of Virology (NIV) has isolated and cultured the new UK variant of SARS-CoV2, the Indian Council of Medical Research (ICMR) said on Saturday underlining that no other country..
India successfully cultures UK-variant of Sars-CoV-2: ICMR
ICMR-RMRC study on use of saliva for SARS-CoV-2 test shows promise
Careless use of therapies may lead to mutations, says ICMRThe Indian Council of Medical Research (ICMR) warned against non-judicious use of therapies that have not been established for treating Covid-19 because it can lead to immune pressure on SARS-CoV2..
Non-judicious use of therapies for Covid-19 leads to virus mutations: ICMR chief"Those therapies which are being touted as 'anti-viral' or 'anti-Covid therapies' and they have do not have benefits established in a scientific research paper, those therapies should not be used as..
3rd serosurvey to cover health workers: ICMRA third Covid-19 serosurvey by the Indian Council of Medical Research is set to assess the infection’s spread among health workers in India. The survey, which began on Thursday, is expected to..
Bharat Biotech bosses discuss Covaxin status with Vice President M Venkaiah NaiduThey discussed the status of the indigenous vaccine, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology, and the plans..
Also reported by •DNA
Indian vaccine Covaxin has drawn global attention: ICMRThe Indian Council of Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. In a tweet, the ICMR said, "India's indigenous vaccine against..
New coronavirus strain not found in samples tested in India, says ICMR-NARI directorThe director said that 7 to 11 sub-types of coronavirus are already known but not each one that is identified needs to be seen with panic.
DNA Analysis: How air pollution is bigger threat than we perceiveICMR has released statistics on deaths from pollution. According to these figures, in 2019, 16 lakh deaths have occurred due to pollution in India.
‘Pollution killed 1.7m in India in 2019, behind 18% of all deaths’Air pollution killed nearly 1.7 million people in India in 2019, accounting for an alarming 17.8% of all deaths in the country in the year, a new paper written as a collaborative effort by Indian..
ICMR chief Balram Bhargava admitted to AIIMS after testing positive for COVID-19This comes as India's COVID-19 caseload rose to 99.79 lakh with 22,890 new infections being reported in a day.
ICMR chief Balram Bhargava undergoing treatment for Covid-19 at AIIMS Trauma CentreIndian Council of Medical Research (ICMR) Director General Balram Bhargava is undergoing treatment for Covid-19 at the AIIMS Trauma Centre here, official sources said on Friday. Bhargava, who is also a..
Entire population may not need to be vaccinated: ICMRDr Bhargava and health secretary Rajesh Bhushan also said a decision is yet to be taken on whether those who have been infected by the disease and recovered need to be administered the vaccine. While..
‘Adverse event’ won’t affect vaccine rollout plan: GovernmentICMR director general Dr Balram Bhargava said adverse events occur with drugs, vaccines or any other health interventions. It is the role of the regulator after collating all the data to ascertain or..
PM Modi reaches Hyderabad to visit Bharat Biotech plantPM Modi will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the AF base, officials said. Covid-19 vaccine, Covaxin, being developed..
ICMR nod for CCMB's dry swab testing for Covid-19
India had estimated 74 million Covid-19 infections by August: ICMR's 2nd national serosurvey
13 crore Covid-19 tests done so far, cumulative positivity rate falling steadily: Health ministryAccording to the Indian council of medical research (ICMR), over 13.06 crore samples have been tested till November 20 with 10,66,022 being tested on Friday. Higher volumes of testing eventually lead..
Troubling trend: India test numbers fall, RAT share remains highWidespread use of RAT, in some cases up to 90% of all tests, has raised fears that a large number of positive cases could be missed. As per the ICMR protocol, every positive report from RAT can be..
Covid-19: Indiscriminate use of Convalescent Plasma Therapy not advisable, says ICMR
First time since August, daily tests below 9 lakh for 3 daysDaily Covid-19 cases in India rose to over 38,000 on Tuesday after dropping below 30,000 the previous day but the number of tests conducted in the country continued to remain low for the fourth day..
Third wave in Covid-19 cases has come now in Delhi: ICMRA third spike in Covid-19 cases has come now in Delhi which is showing more cases than before, with factors like pollution, cold weather and festivals playing a major role in the rise of the..
India-made COVID-19 vaccine could be launched as early as this month, know whenBharat Biotech, a private company that is developing COVAXIN with the government-run Indian Council of Medical Research (ICMR), had earlier hoped to launch it only in the second quarter of next year.
Bharat Biotech to launch Covaxin in Q2 2021Bharat Biotech is planning to launch its vaccine for Covid-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities, a top company official said. The..
BCG vaccine could help elderly fight Covid: ICMRThe nearly century-old Bacille Calmette-Guérin (BCG) vaccine can help the elderly fight off infections such as Covid-19, a study by the Indian Council of Medical Research has said. The researchers..